Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

45.85
+1.673.79%
Volume:2K
Turnover:95.66K
Market Cap:5.73M
PE:- -
High:45.88
Open:44.96
Low:44.81
Close:44.17
52wk High:45.88
52wk Low:25.71
Shares:125.00K
Float Shares:125.00K
Volume Ratio:1.06
T/O Rate:1.68%
Dividend:0.62
Dividend Rate:1.36%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 20

Sweden's Medivir Q2 Turnover Falls

Reuters
·
Aug 20

Glenmark Wins U.S. FDA Nod for Generic Flonase Nasal Spray

TIPRANKS
·
Aug 20

Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026

TIPRANKS
·
Aug 20

Telix Swings to H1 FY26 Net Profit of US$38 Million; Revenue Rises 22% to Us$477 Million

Reuters
·
Aug 20

Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results

Dow Jones
·
Aug 20

Crinetics Faces Shareholder Challenges to Vertex Merger Deal

TIPRANKS
·
Aug 20

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

Dow Jones
·
Aug 20

Vertex Pharmaceuticals Inc Stock (VRTX) Closed Up by 4.48% on Aug 19: Drivers Behind the Movement

TradingKey
·
Aug 20

Regeneron to Webcast Management Presentation at Wells Fargo Healthcare Conference

Reuters
·
Aug 20

Regeneron Announces Investor Conference Presentations

GlobeNewswire
·
Aug 20

Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition

MT Newswires Live
·
Aug 20

Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know

TradingKey
·
Aug 20

US FDA Approves Regeneron's Rare Bone Disorder Drug

Reuters
·
Aug 20

Regeneron Says FDA Approves Pasatru for Adults with Rare Bone Disorder FOP

Reuters
·
Aug 20

Regeneron Pharmaceuticals, - Pasatru Under Review by European Medicines Agency; Global Submissions Planned

THOMSON REUTERS
·
Aug 20

Regeneron Pharmaceuticals, - FDA Approves Pasatru (Garetosmab-Grts) for Adults with Fibrodysplasia Ossificans Progressiva

THOMSON REUTERS
·
Aug 20

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live
·
Aug 19

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19

Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb

Dow Jones
·
Aug 19